Trial Profile
Phase III bone mass test of MN-10-T against primary osteoporosis with high risk of fracture
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Registrational; Therapeutic Use
- Sponsors Asahi Kasei Pharma Corp
- 22 Sep 2017 New trial record